FDA Inspection 1319888 — Martha Tarpay, M.D.
The FDA completed an inspection of Martha Tarpay, M.D. on May 8, 2026 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)